GT Biopharma Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.
The company stated in the following press release that they use animals for product testing.
“Two animal models were tested. One in ovarian cancer and one in head and neck cancers. In the ovarian cancer model, animals that were treated with our CD16-IL15-B7H3 TriKE demonstrated significant tumor resolution.” Read the following article
GT Biopharma, Inc. is a clinical-stage, biopharmaceutical company. The Company is focused on the development of novel immuno-oncology products based on its Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. The Company’s TriKE platform generate therapeutics designed to harness and enhance the cancer killing abilities of a patient’s own natural killer (NK) cells.
Company Website: https://www.gtbiopharma.com